DAE HWA PHARM CO., LTD
067080 | KO
Overview
Corporate Details
- ISIN(s):
- KR7067080002
- LEI:
- Country:
- South Korea
- Address:
- 강원도 횡성군 횡성읍 한우로 495, 횡성군
- Website:
- http://www.dhpharm.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 34.5 KB | ||
| 2025-09-19 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 31.8 KB | ||
| 2025-09-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 158.8 KB | ||
| 2025-08-11 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.7 MB | ||
| 2025-08-06 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
|
Korean | 8.3 KB | ||
| 2025-08-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 158.8 KB | ||
| 2025-06-12 00:00 |
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
|
Korean | 5.4 KB | ||
| 2025-06-12 00:00 |
Related Party Transaction
[기재정정]타인에대한채무보증결정
|
Korean | 24.3 KB | ||
| 2025-06-12 00:00 |
Capital/Financing Update
[기재정정]타인에대한담보제공결정
|
Korean | 25.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-04-29 00:00 |
Regulatory Filings
투자판단관련주요경영사항 (리포락셀액(파클리탁셀)의 품목허가사항 변경신청 (유방암 신규 적응증 추가를 위한 식품의약품안전…
|
Korean | 16.5 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB |
Automate Your Workflow. Get a real-time feed of all DAE HWA PHARM CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DAE HWA PHARM CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAE HWA PHARM CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.
United States of America
CYTK
United States of America
CYTK
Develops tumor-activated antibody therapeutics for more targeted, less toxic cancer treatments.
United States of America
CTMX
United States of America
CTMX
Develops devices and cell therapies using a patient's fat tissue to repair injury and treat disease.
Japan
3750
Japan
3750
Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.
South Korea
078140
South Korea
078140
Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.
South Korea
023910
South Korea
023910
Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.
South Korea
036480
South Korea
036480
A global R&D partner for drug development, manufacturing, and commercialization services.
South Korea
069620
South Korea
069620